Quantcast
Last updated on April 20, 2014 at 17:20 EDT

Latest APL Stories

2012-11-20 13:40:37

May provide treatment option for those with harder-to-treat memory problems, skin ulcers and kidney disease Rituximab, a drug used to treat cancer and arthritis, may help patients with antiphospholipid antibodies (aPLs) who suffer from aPL-related clinical problems that do not respond to anticoagulation, such as cardiac disease and kidney disease, according to a new study by rheumatology researchers at Hospital for Special Surgery. The study appears online ahead of print, in the journal...

2012-11-12 11:58:24

New research suggests that statins, traditionally used for cholesterol lowering, could be used in the management of individuals who are at risk for developing clotting because they have autoimmune antiphospholipid antibodies (aPL). The research will be presented in two presentations at the annual meeting of the American College of Rheumatology/Association of Rheumatology Health Professionals (ACR/ARHP). The meeting will be held Nov. 9-14, in Washington D.C. "What we have shown is that...

NASA Renames Radiation Belt Mission
2012-11-10 09:36:40

April Flowers for redOrbit.com — Your Universe Online NASA announced the renaming of a recently launched mission to study the radiation belts to the Van Allen Probes in honor of the late James Van Allen, head of the physics department at the University of Iowa. Van Allen discovered the radiation belts encircling Earth in 1958. NASA announced the new name, previously the Radiation Belt Storm Probes (RBSP), at a ceremony at the Johns Hopkins University Applied Physics Laboratory...

2012-10-25 11:25:28

WOODCLIFF LAKE, N.J., Oct. 25, 2012 /PRNewswire/ -- Par Pharmaceutical Companies, Inc. today announced that its operating subsidiary, Anchen Pharmaceuticals, Inc., has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for tretinoin capsules, 10 mg. Tretinoin capsules is the generic version of Vesanoid(®) capsules and is used in the treatment of acute promyelocytic leukemia. Par expects to begin shipping the product before the end...

2012-10-24 15:22:24

PHILADELPHIA, Oct. 24, 2012 /PRNewswire/ -- Atlas Pipeline Partners, L.P. (NYSE: APL) ("APL", "Atlas Pipeline", or the "Partnership") announced today that the Partnership has declared a quarterly cash distribution for the third quarter of 2012 of $0.57 per common limited partner unit, payable Wednesday, November 14, 2012 to holders of record as of Wednesday, November 7, 2012. The third quarter distribution of $0.57 per common limited partner unit is the 8(th) increase in the...

2012-10-22 15:21:47

PHILADELPHIA, Oct. 22, 2012 /PRNewswire/ -- Atlas Pipeline Partners, L.P. (NYSE: APL) ("APL", "Atlas Pipeline", or the "Partnership") announced today that it will release its results for the third quarter of 2012 on Tuesday, October 30, 2012 after market hours, and invites investors and other interested parties to listen to the live webcast of its quarterly conference call on Wednesday, October 31, 2012 at 10:00 a.m. Eastern Time. This call is being webcast live and can be accessed by...

2012-09-24 10:23:32

PHILADELPHIA, Sept. 24, 2012 /PRNewswire/ -- Atlas Pipeline Partners, L.P. (NYSE: APL) ("APL", "Atlas Pipeline", or the "Partnership") announced today that it intends to offer $300 million of Senior Notes due 2020 in a private placement, subject to market conditions. The Partnership intends to use the net proceeds from this offering to repay a portion of its outstanding indebtedness under its revolving credit facility. The notes will not be registered under the Securities Act of 1933 or the...

2012-08-21 10:21:04

PHILADELPHIA, Aug. 21, 2012 /PRNewswire/ -- Atlas Pipeline Partners, L.P. (NYSE: APL) ("APL", "Atlas Pipeline", or the "Partnership") announced today that it will be participating in two upcoming energy conferences. Partnership management will be hosting meetings at the Citi MLP Conference on August 22-23, 2012 in Las Vegas, NV. Additionally, management from Atlas Pipeline will participate in the Barclay's Energy Conference on September 4-6, 2012 in New York City, and will be...

2012-08-01 10:23:49

PHILADELPHIA, Aug. 1, 2012 /PRNewswire/ -- Atlas Pipeline Partners, L.P. (NYSE: APL) ("APL", "Atlas Pipeline", or the "Partnership") today reported record volumes at all three of its gathering and processing systems for the second quarter of 2012 as expansion efforts continue across the Partnership. Processed volumes have increased significantly versus the second quarter of 2011 and each operating area is either at full processing capacity or operating at a high utilization rate. The...

2012-07-18 10:22:16

PHILADELPHIA, July 18, 2012 /PRNewswire/ -- Atlas Pipeline Partners, L.P. (NYSE: APL) ("APL", "Atlas Pipeline", or the "Partnership") announced today that it will release its results for the second quarter of 2012 on Wednesday, August 1, 2012 after market hours, and invites investors and other interested parties to listen to the live webcast of its quarterly conference call on Thursday, August 2, 2012, at 9:00 a.m. Eastern Time. This call is being webcast live and can be accessed by...